c-erbB-2 protein overexpression and p53 immunoreaction in primary and recurrent breast cancer tissues

Abstract

c-erbB-2 and p53 expression levels in breast cancer cells were almost unchanged as the disease progressed and/or in response to adjuvant therapies, regardless of the hormone receptor status.